Shashank Neupane

Shashank Neupane

Auto-generated profile, based on publicly available information

Shashank Neupane

Nepalese Army Institute of Health Sciences

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2022 in The Journal of Clinical Hypertension
Verified
Journal Article
Open access
LBLaxman Bhusal
Laxman Bhusal
BPBishnu Deep Pathak
Bishnu Deep Pathak
BDBishal Dhakal
Bishal Dhakal
NSNabin Simkhada
Nabin Simkhada
NSNeeraj Sharma
Neeraj Sharma
DSDhan Bahadur Shrestha
Dhan Bahadur Shrestha
The study aimed to determine the level of self‐reported adherence to antihypertensive drug(s) and its associated factors among patient with hypertension at a tertiary care center. The authors performed hospital based observational cross‐sectional study using semi‐structured questionnaires, WHO STEP tool and Hill and Bone high blood pressure compliance scale from December 1, 2021 to February 28, 2022. Descriptive statistics, Chi‐square/Fisher's exact test and non‐parametric tests were used for statistical analysis. Among 150 cases included in the study, majority (94, 62.67%) had good adherence based on Hill and Bone high blood pressure compliance scale with adherence level labelled as “good adherence” (score 3) and “not good adherence” (score < 3). The adherence to drug therapy was significantly better in females compared to males (50 [71.43%] vs. 44 [55.00%], p = .038). Among the factors related to hypertension and anti‐hypertensive therapy, people with higher body mass index (ρ = ‐.324, n = 56, p = .015) and taking three or more pills (6, 1.71%, p = .017) had lower adherence to therapy. Likewise, forgetfulness (30, 53.57%), ineffective counseling (7, 12.50%), and missed follow‐up (13, 23.21%) were the factors associated with lower adherence to anti‐hypertensive therapy. This study finds good adherence among the patients taking anti‐hypertensive medications. However, with the improved education, lesser number of pills and physical fitness help to adhere with the anti‐hypertensive therapy.

20 December 2022 in Clinical Case Reports
Verified
Journal Article
Open access
BDBishal Dhakal
Bishal Dhakal
SDSagun Dawadi
Sagun Dawadi
LKLaxman Khadka
Laxman Khadka
SBSujan Bohara
Sujan Bohara
SNShashank Neupane
Shashank Neupane
BRBinit Upadhaya Regmi
Binit Upadhaya Regmi
Ciprofloxacin, among the many Fluoroquinolones, has been widely used as a broad‐spectrum antibiotic due to its wide range of action and relatively safe adverse effect profile. However, among the cutaneous adverse drug reactions due to Ciprofloxacin, toxic epidermal necrolysis occurring along with cholestatic hepatitis is a rare one. Here, we present a case of a 22‐year‐old male patient who was diagnosed with toxic epidermal necrolysis with cholestatic hepatitis secondary to Ciprofloxacin. Naranjo adverse drug reaction probability scale was used for the causal association.

15 April 2022 in Journal of Nepal Medical Association
Verified
Journal Article
Open access
SNShashank Neupane
Shashank Neupane
PPPrasamsa Pudasaini
Prasamsa Pudasaini
ASAnupam Sharma
Anupam Sharma
SSShriya Sharma
Shriya Sharma
AAAakriti Adhikari
Aakriti Adhikari
KRKumar Roka
Kumar Roka
Minimal change disease is an important cause of nephrotic syndrome in children, however, few cases are seen among adults. There is very little literature regarding the occurrence of minimal change disease in adults. We reported a case of a 63-year-old male who presented with the complaint of swelling around the eyes mostly during the morning for 18 days and frothing of urine for 7 days. On examination, the patient was ill-looking and had edema around the eyes and over the ankles. After preliminary investigations, renal biopsy was performed and electron microscopy revealed diffuse effacement of foot processes of visceral epithelial cells suggesting minimal change disease (podocytopathy). The patient has been treated with tablet prednisolone 60 mg per oral once daily, tablet ramipril 2.5 mg per oral once daily, and tablet torsemide 20 mg per oral twice daily. Hence, minimal change disease should also be considered as a differential diagnosis in adults presenting with the features of nephrotic syndrome.

1 October 2022 in Journal of Nepal Medical Association
Verified
Journal Article
Open access
PDF file
SNShashank Neupane
Shashank Neupane
PPPrasamsa Pudasaini
Prasamsa Pudasaini
BDBishal Dhakal
Bishal Dhakal
SAShila Awal
Shila Awal
STSajeena Thapa
Sajeena Thapa
BSBinaya Subedi
Binaya Subedi
Protein S is a vitamin K-dependent protein that acts as a break in secondary hemostasis by inactivating activated factor V and activated factor VIII. We report a case of a 40 years old male who had the first episode of deep vein thrombosis of the left lower limb 10 years back, which despite treatment, reoccurred 3 months later in the bilateral lower limb. Thrombophilic screening showed severe protein S deficiency. The patient then developed deep vein thrombosis of both upper limbs. The patient was advised to place an inferior vena cava filter, which he denied. The patient is now presenting with multiple episodes of post-thrombotic syndrome. Such attacks are treated with elastic compression stockings, rivaroxaban, and morphine. However, despite medication, the pain has not yet subsided. Hence, even though protein S deficiency is the rare cause of deep vein thrombosis when recurrent should be considered despite its rare occurrence.

12 December 2022 in Clinical Case Reports
Verified
Journal Article
Open access
SSShriya Sharma
Shriya Sharma
AAAakriti Adhikari
Aakriti Adhikari
NGNirmal Ghimire
Nirmal Ghimire
GMGaurab Mainali
Gaurab Mainali
SYSumit Kumar Yadav
Sumit Kumar Yadav
SNShashank Neupane
Shashank Neupane
Hemophagocytic Lymphohistiocytosis (HLH) is a rare life‐threatening condition characterized by widespread activation of the immune system leading to tissue damage all over the body. It is divided into primary HLH due to inborn error in lymphocytes, T cells, and macrophages and secondary HLH which is mostly due to infections, systemic connective tissue diseases, and lymphoid malignancies. Here, we report a 34‐year‐old man with a history of high‐grade fever, chills, and rigor, eschar, splenomegaly with the laboratory findings of thrombocytopenia, hypochromic RBCs with anisocytosis and basophilic stippling, elevated transaminases, and a positive Weil Felix test along with positive PCR results for Orientia tsutsugamushi and the presence of IgG and IgM antibodies. A detailed workup was done to rule out other etiology for fever. Diagnosis of HLH secondary to Rickettsia infection was made with a thorough history, clinical evaluation, and a variety of investigations. The patient was treated with Doxycycline, Ciprofloxacin, Etoposide, and Dexamethasone but unfortunately, the patient died during treatment due to multiorgan failure. Patients with scrub typhus typically respond well to therapy; therefore, early detection and antibiotic treatment can help avoid serious complications. Scrub typhus with the hemophagocytic syndrome can result in DIC and multiorgan failure. Despite its rarity, scrub typhus may be lethal; as a result, practitioners must be aware of the necessity of detecting and treating suspected cases as soon as possible. We learned that a systematic diagnostic approach, use of diagnostic criteria, and prompt treatment are very crucial in this disease.

22 January 2024 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
SNShashank Neupane
Shashank Neupane
PPPrasamsa Pudasaini
Prasamsa Pudasaini
BDBishal Dhakal
Bishal Dhakal
PSPasang Sherpa
Pasang Sherpa
PRPooja Rokaya
Pooja Rokaya
ASAnukul Subedi
Anukul Subedi
Introduction and importance: Tolosa-Hunt syndrome is a rare condition with unknown aetiology that manifests clinically as unilateral orbital pain and ophthalmoplegia. It is a diagnosis of exclusion that resolves spontaneously but can recur and respond dramatically to systemic steroids. Case presentation: The authors herein report a case of a 38-year-old male who presented with horizontal diplopia, limited outward movement of the right eye, and blurry vision for two days which was managed with oral Prednisolone. The patient visited 3 months later with progressive ptosis and vertical diplopia with periorbital pain over the right eye. It was eventually diagnosed via magnetic imaging resonance studies and successfully treated for Tolosa-Hunt syndrome with IV methylprednisolone followed by oral prednisolone. Clinical discussion: Hence, the typical clinical presentation of the case with significant response to steroids, exclusion of other conditions from investigation and imaging, and subsequent recurrence of similar symptoms were crucial for making the diagnosis of Tolosa-Hunt syndrome. Conclusion: Tolosa-Hunt syndrome is a syndrome of painful ophthalmoplegia which responds well to steroid therapy but has a tendency to recur. Hence, patients must be adequately informed about the reoccurrence and kept under follow-up.